Pathophysiology of hypertension during preeclampsia: Role of inflammatory cytokines

Current Hypertension Reviews

Volumn 3, Issue 1, 2007, Pages 69-74

  LaMarca, Babbette D ^a   Ryan, Michael J ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Endothelin (ET 1); IL 6; Rennin angiotensin system (RAS); Tumor necrosis factor (TNF) alpha

Indexed keywords

CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 6; NEUROHORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; ENDOTHELIUM LESION; HUMAN; IMMUNOSTIMULATION; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; MATERNAL HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR ENDOTHELIUM;

EID: 34247124663     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340207779815482     Document Type: Review

References (38)

1. Saftlas AF, Olson DR, Franks AL, Atrash HK and Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990; 163: 460-465.
2. August P and Lindheimer MD. Pathophysiology of preeclampsia. Hypertension 1995; 142(2): 2407-2426
3. Ashworth JR, Baker Pn, Warrend AY. Plasma from preeclamptic women induces a functional change in myometrial resisitance arteries. J Soc Gynecol Invest 1997; 4(aupple 1): 71.
4. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta. 2002 May; 23(5):359-72.
5. Roberts JM, Taylor RN and Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclmpsia. Am J Hypertens. 1991; 4: 700-708.
6. Pober JS, Coltran RS.Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51.
7. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 Mar, 111(5):649-58
8. Wallakut G. Homuth V, Fischer T, et al. Pateints with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999 April; 103(7): 945-952.
9. Fisher SJ and Martin JM. In: Chelsey's 2nd Ed, Hypertensive Disorder in Pregnancy. Appleton and Lange, M Lindheimer, JM Roberts and FG Cunningham, 1998; 377-394.
10. Saito S, Sakai M. Th1/Th2 balance in preeclampsia J Reprood. Immunol. 2003 Aug; 59(2): 161-173.
11. Zenclussen AC, Fest S, Joachim R, Klapp B F and Arck PC. Introducing a mouse model for pre-eclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol 2004; 34: 377-387.
12. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta J Clen Endocrinol Metab 1997; 82: 1582-1588.
13. Conrad KP and Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod.Immun 1997; 37(3): 240-249.
14. Funakoshi Y, Ichiki T, Ito K, Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 1999; 34: 118-125.
15. Han Y, Runge MS, Braiser AR. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 1999; 84: 695-703.
16. Lee DL, Sturgis LC, Labazi H, et al. Angiotensin II Hypertension is Attenuated in Interleukin-6 Knockout Mice. Am J Physiol Heart Circ Physiol 2006; 288(1): H000-H000.
17. Ruiz-Ortega M, Ruperez M, Lorenzo O, et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 2002; 82: 12-22.
18. Zhang ZH, Wei SG, Francis J and Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 2003; 284: R916-R927.
19. LaMarca BBD, Bennett WA, Alexander BT, Cockrell K and Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of tumor necrosis factor alpha. Hypertension. 2005 Oct; 46(4): 1022-5.
20. Granger JP, LaMarca BBD, Cockrell K, et al. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 2006; 122: 383-392.
21. Taylor RN, Varma M, Teng NN, Roberts JM. Women with preeclampsia have higher plasma endothelia levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71(6): 1675-1677.
22. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of Hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38(3 Pt 2): 718-722.
23. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002, 283: R29-R45.
24. Giovanni Gadonski, B. Babbette D. Lamarca, Sullivan E, Bennett W, Derrick Chandler, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of Interleukin-6. Hypertension (In Press)
25. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats.
26. Hypertension 2005; 46(1): 82-86.
27. Wilkins FC Jr, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol Regul Integr Comp Physiol 1995; 268: R375-R381.
28. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin-A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37: 485-489.
29. Roberts L, LaMarca B, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 2006; 47(3): 615-618.
30. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol 1992; 262: C854-C861.
31. Dechend R, Homuthe V, Wallukat G, et al. AT1 Receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000; 101: 2382-2387.
32. Walther T, Wallukat G, Alexander J, et al. Angiotensin II Type 1 Receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension. 2005 Dec; 46: 1275-1279.
33. Minagawa M, Narita J, Tada T, et al. Abo T Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system.Cell Immunol. 1999 Aug 25; 196(1): 1-13.
34. Schobel HP, Grassi G. Hypertensive disorders of pregnancy: a dysregulation of the sympathetic nervous system? J Hypertens. 1998 May; 16(5): 569-70.
35. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. N Engl J Med. 1996 Nov 14; 335(20): 1480-5.
36. Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M. Effects of interleukin-1 beta an blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 1992 Apr; 5(4 Pt 1): 224-9.
37. Ye S, Mozayeni P, Gamburd M, Zhong H, Campese VM. Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol 2000 Dec; 279(6): H2786-H2796.
38. Campese VM, Ye S, Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002 Feb; 39(2 Pt 2): 519-24.